Herbs (Global Traditional) · Ayurveda
Vetiver (Vetiveria zizanioides) (Vetiveria zizanioides)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Vetiver (Vetiveria zizanioides) contains vetiverol, vetivenene, and khusimene compounds that demonstrate antioxidant and antimicrobial properties. The essential oil acts on GABA receptors and exhibits free radical scavenging activity in laboratory studies.
Vetiver (Chrysopogon zizanioides, formerly Vetiveria zizanioides) is a perennial grass native to India, with roots primarily sourced from tropical regions including Indonesia and Haiti for essential oil production. The oil is extracted from the roots via steam distillation, supercritical CO2 extraction, or hydrodistillation, yielding a viscous, amber-colored essential oil rich in sesquiterpenes (50-90% of composition).
The research dossier reveals a complete absence of human clinical trials, RCTs, or meta-analyses for vetiver. No PubMed PMIDs for human studies on biomedical applications are available, with existing research limited to chemical composition analysis, in vitro antioxidant testing, and antimicrobial activity studies.
No clinically studied dosage ranges are available as human trials are absent. The research does not specify therapeutic doses for any form (extract, powder, or standardized oil). Consult a healthcare provider before starting any new supplement.
Vetiver (Vetiveria zizanioides) is not consumed as a food source and therefore lacks a conventional nutritional profile of macronutrients (protein, carbohydrates, fats, fiber). Its value lies entirely in its bioactive phytochemical composition, primarily concentrated in the essential oil extracted from its roots. Key bioactive compounds include: **Sesquiterpenes and sesquiterpenoids** (comprising >95% of the essential oil): • Vetiverol (vetiver alcohol) — approximately 45–65% of root essential oil; primary bioactive sesquiterpenol with reported sedative and antioxidant activity. • Vetivone (α-vetivone and β-vetivone) — approximately 4–12% of essential oil; bicyclic ketones with demonstrated antimicrobial properties. • Khusimol — approximately 3–15% depending on chemotype and geographic origin; sesquiterpene alcohol contributing to biological activity. • Isovalencenol — approximately 2–8%; sesquiterpenoid with anti-inflammatory potential. • Zizanal and epizizanal — minor constituents (~1–3%); aldehydes with reported bioactivity. • Khusimone — approximately 1–5%. **Other notable compounds**: • Vetiveric acid — present in trace amounts in root extracts. • Phenolic compounds — present in aqueous/ethanolic extracts (not essential oil); contribute to in-vitro antioxidant (DPPH scavenging) activity; total phenolic content of root extracts reported at approximately 15–45 mg gallic acid equivalents per gram of dry extract depending on solvent system. • Flavonoids — detected in root extracts at approximately 5–20 mg quercetin equivalents per gram dry extract. **Mineral content of root material** (approximate, per 100g dry root): Potassium, calcium, magnesium, iron, and zinc are present in trace-to-moderate levels typical of fibrous grass roots, but vetiver roots are not consumed for mineral nutrition. **Bioavailability notes**: Essential oil constituents are lipophilic with moderate dermal absorption (relevant for topical Ayurvedic applications such as medicated oils). Oral bioavailability of sesquiterpenoids is generally low due to extensive first-pass hepatic metabolism and poor aqueous solubility. Traditional Ayurvedic preparations (kashayam/decoctions, arishtam/fermented preparations) may extract water-soluble phenolics and flavonoids more efficiently than lipophilic terpenoids. No human pharmacokinetic data are currently available for isolated vetiver compounds.
Vetiver essential oil contains vetiverol and khusimene that modulate GABA neurotransmitter activity, promoting relaxation and reducing anxiety. The sesquiterpene compounds demonstrate free radical scavenging through electron donation mechanisms. Antimicrobial activity occurs via disruption of bacterial cell membrane integrity and inhibition of fungal growth.
Current evidence is limited to preliminary in vitro studies demonstrating antioxidant activity with IC50 values ranging from 15-30 μg/mL for DPPH radical scavenging. Laboratory antimicrobial testing shows activity against Staphylococcus aureus and Candida albicans with MIC values of 125-250 μg/mL. Human clinical trials evaluating vetiver's anxiolytic effects or therapeutic applications are lacking. Traditional use in Ayurvedic medicine supports its calming properties, but controlled studies are needed to validate clinical efficacy.
Vetiver is generally recognized as safe when used topically in diluted essential oil preparations. Oral consumption safety data is limited, and high doses may cause gastrointestinal irritation. Potential interactions with sedative medications due to GABAergic activity require caution. Pregnancy and breastfeeding safety has not been established through clinical studies.
